Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 6/20 | 0.47 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.41 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.41 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14334483 | 1.00 | IRAK4 (0.47) | IRAK4CHRNB4CHRNA3RAB9AACHE | |
| SCHEMBL14334484 | 0.86 | CHRNB4 (0.46) | IRAK4CHRNB4CHRNA3CHRNB1CHRNB2 | |
| SCHEMBL14334460 | 0.86 | CHRNB4 (0.46) | IRAK4CHRNB4CHRNA3CHRNB1CHRNB2 | |
| SCHEMBL10271868 | 0.82 | CHRNB4 (0.48) | IRAK4CHRNB4CHRNA3HCRTR2HCRTR1 | |
| SCHEMBL14335146 | 0.80 | CYP4F2 (0.49) | IRAK4ACHEROCK2 | |
| SCHEMBL14334294 | 0.79 | IRAK4 (0.60) | IRAK4ACHEROCK2 | |
| SCHEMBL5955514 | 0.76 | ACHE (0.51) | IRAK4RAB9AACHEROCK2 | |
| SCHEMBL30359409 | 0.76 | ACHE (0.51) | IRAK4RAB9AACHEROCK2 | |
| SCHEMBL30881547 | 0.75 | CHRNB4 (0.61) | CHRNB4CHRNA3CHRNB1CHRNB2CHRNA4 | |
| SCHEMBL14377503 | 0.75 | CHRNB4 (0.44) | IRAK4CHRNB4CHRNA3ACHECHRNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012176123-A1 | 3 - IMIDAZOLYL- INDOLES FOR THE TREATMENT OF PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 2012-12-27 | — | — | WO | disclosed |